Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING

Ian T. Meredith,Stephan Windecker,Josep Rodés-Cabau,Tommy C. Lee, Arthur Reitman,Andrejs Erglis, Mark Dorogy,Barry D. Bertolet,Louis Cannon,Juhani Airaksinen, Craig Siegel,Thomas Christen,Dominic J. Allocco,Keith D. Dawkins

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2017）

Cited 2|Views34
No score
Abstract
Background: Although drug-eluting stents reduce cardiac events compared with bare metal stents, permanent polymers may result in chronic inflammation, delayed arterial healing and increased risk of late cardiac events. Resorbable polymers may reduce inflammation and mitigate late/ very-late adverse
More
Translated text
Key words
evolve ii randomized trial,late clinical outcomes,clinical outcomes,randomized trial,three-year,everolimus-eluting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined